^
    BIOMARKER:

    HER-2 expression

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2




    Show legend

    Include preclinical:
    Gastric Cancer
    HER2 Positive Breast Cancer
    Solid Tumor
    Colorectal Cancer
    Breast Cancer
    Biliary Tract Cancer
    Non Small Cell Lung Cancer
    Endometrial Adenocarcinoma
    Gastroesophageal Junction Adenocarcinoma
    Salivary Gland Cancer
    Endometrial Cancer
    Cholangiocarcinoma
    Urothelial Cancer
    Bladder Cancer
    Gastrointestinal Cancer
    Pancreatic Cancer
    Gastroesophageal Cancer
    Pancreatic Adenocarcinoma
    Lung Cancer
    Cervical Cancer
    Uterine Cancer
    Ovarian Cancer
    Childhood B Acute Lymphoblastic Leukemia
    Colon Cancer
    Rhabdomyosarcoma
    fam-trastuzumab deruxtecan-nxki
    trastuzumab
    ARX788
    SHR-A1811
    trastuzumab + lapatinib
    disitamab vedotin
    A166
    KN026
    XMT-1522
    pertuzumab + ado-trastuzumab emtansine
    BNT323
    DF1001
    BL-M07D1
    ZW25
    PF-06804103
    SBT6050
    BDC-1001
    AST-301
    ado-trastuzumab emtansine
    avelumab
    cetuximab
    trastuzumab + tucatinib
    lapatinib
    trastuzumab + pertuzumab
    nivolumab + fam-trastuzumab deruxtecan-nxki
    trastuzumab + erlotinib + gemcitabine
    pembrolizumab + margetuximab
    toripalimab-tpzi + disitamab vedotin
    pembrolizumab + SBT6050
    nivolumab + BDC-1001
    DP303c
    ZW49
    PRO1102
    panitumumab
    MT-5111
    ado-trastuzumab emtansine + AST-301
    paclitaxel
    tucatinib
    afatinib
    ABL105
    GDA-501
    fam-trastuzumab deruxtecan-nxki + AZD1775
    BAY2701439
    ORM-5029
    T-lymphocyte cell therapy